Intracranial hypertension after MECT: successful transition to rTMS for refractory auditory hallucinations: a case report
-
By
-
Liang Lv
-
Meng-Yun Guan
-
July 13, 2026
Management of Intracranial Hypertension Following MECT: A Case Study
Background
Schizophrenia is characterized by persistent auditory hallucinations, affecting 60%-80% of patients. Treatment-resistant auditory hallucinations pose significant challenges, as first-line antipsychotic medications often fail. MECT can lead to adverse effects such as intracranial hypertension.
Data Highlights
No numerical data was provided in the source material.
Key Findings
- A 21-year-old female with schizophrenia developed intracranial hypertension after MECT.
- She experienced severe symptoms including headache, vomiting, and diplopia.
- Following rTMS treatment, her auditory hallucinations diminished significantly within 3 days.
- Her symptoms resolved completely within one week, with improved social functioning.
- No recurrence of symptoms was observed during a 3-week follow-up.
Clinical Implications
Monitoring for elevated intracranial pressure following MECT is important, especially in patients with a history of migraine.
Conclusion
This case suggests the need for further investigation into rTMS for managing refractory auditory hallucinations in patients with a history of intracranial hypertension post-MECT.
Related Resources & Content
- Frontiers in Psychiatry, 2026 -- Factors associated with treatment-emergent headache occurrence following RTMS to non-motor areas and the impact on treatment outcomes
- Frontiers in Psychiatry, 2026 -- Retrospective evaluation of transcranial magnetic stimulation for enhancing arousal in patients with minimally conscious state
- JAMA Network Open, 2023 -- Intermittent Theta-Burst Stimulation for Depression—Delineating Specific and Nonspecific Effects
- Electroconvulsive Therapy - StatPearls, NCBI Bookshelf
- Clinical Practice Guidelines for the Use of Electroconvulsive Therapy, PMC
- Frontiers in Neurology — The safety of Ipsilateral high-frequency repetitive Transcranial Magnetic Stimulation in brain tumour patients
- Diagnosis, treatment and monitoring of idiopathic intracranial hypertension: Consensus recommendations of the Austrian IIH network (AN4IH), 2025
- Electroconvulsive Therapy - StatPearls - NCBI Bookshelf
- Clinical Practice Guidelines for the Use of Electroconvulsive Therapy - PMC
- Theta burst stimulation of temporo-parietal cortex regions for the treatment of persistent auditory hallucinations: a multicentre, randomised, sham-controlled, triple-blind phase 3 trial in Germany - ScienceDirect
- Efficacy of non-invasive brain stimulation in treatment-resistant schizophrenia: A systematic review and network meta-analysis - ScienceDirect
- Frontiers | Efficacy and safety of rTMS for global symptom severity, negative symptoms, and auditory hallucinations in treatment-resistant schizophrenia: A systematic review and meta-analysis
- https://dpsnet.dk/wp-content/uploads/2025/09/Danish-Psychiatric-Society-TMS-Guidelines-2025.pdf
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.